SavedAdd your journal

Journals / Gazi Medical Journal / 2017 / Cilt: 28 - Sayı: 3

Assessment of Nutritional Status and Metabolic Syndrome in Peritoneal Dialysis Patients: A Pilot Study

Periton Diyalizi Hastalarında Beslenme Durumu ve Metabolik Sendromun Değerlendirilmesi: Bir Pilot Çalışma

Kürşad ÖNEÇ
Nevin ŞANLIER
Gamze AKBULUT
Nilüfer ACAR TEK
Yasemin ERTEN
Pages
191–195
Publication Date
2022-10-19
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Patients with MS had significantly greater systolic/diastolic bloodpressure and lower high-density-lypoprotein cholesterol levels (HDL-C)(p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim:Nutritional deficiencies and metabolic syndrome (MS) is challenge inchronic kidney disease patients with peritoneal dialysis(PD).
📊
Key Findings & Data:The statement of MS was identifiedaccording to MS criteria adopted for PD patients.Results:The prevalence of MS was found 64.3%.
💡
Conclusion & Impact:Patients with MS had significantly greater systolic/diastolic bloodpressure and lower high-density-lypoprotein cholesterol levels (HDL-C)(p
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Aim:Nutritional deficiencies and metabolic syndrome (MS) is challenge inchronic kidney disease patients with peritoneal dialysis(PD). This study wasplanned in order to assess the nutritional status and metabolic syndrome inPD patients.Methods:This study was performed on clinically stable patients that wereundergoing PD therapy. Energy and nutrient intakes were determined withconsequently three days dietary record. The statement of MS was identifiedaccording to MS criteria adopted for PD patients.Results:The prevalence of MS was found 64.3%. The mean duration of PD inwith-MS(35.4±25.23mo.) was lower than without-MS(44.3±30.99mo.)(p>0.05). Patients with MS had significantly greater systolic/diastolic bloodpressure and lower high-density-lypoprotein cholesterol levels (HDL-C)(p

Özet

Amaç: Beslenme yetersizlikleri ve metabolik sendrom (MS), peritoneal diyaliz (PD) alan, kronik böbrek hastalarında ciddi sorunlardır. Bu çalışma PD hastalarında beslenme ve metabolik sendromu durumunu değerlendirmek amacıyla planlanmış ve yürütülmştür. Yöntem: Bu çalışma, PD tedavisi gören klinik olarak stabil hastalar üzerinde gerçekleştirildi. Enerji ve besin öğesi alımları ardışık üç günlük besin tüketim kaydı alınarak belirlendi. MS durumu, PD hastaları için uyarlanan MS kriterlerine göre tanımlandı. Bulgular: MS prevelansı %64.3 bulundu. Ortalama PD süresi MS'li hastalarda (35.4 ± 25.23 ay), MS olmayanlardan (44.3 ± 30.99 ay) daha kısaydı (p> 0.05). MS hastalarında sistolik / diyastolik kan basıncı ve HDL-C düzeyleri anlamlı derecede daha yüksekti (p

🔖

Cite This Article

ÖNEÇ, K., ŞANLIER, N., AKBULUT, G., TEK, N. A., ERTEN, Y. (2022). Assessment of Nutritional Status and Metabolic Syndrome in Peritoneal Dialysis Patients: A Pilot Study. Gazi Medical Journal, Cilt: 28 - Sayı: 3, 191–195. https://ajindex.com/articles/519936

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Barclay L: Metabolic syndrome highly prevalent in dialysis patient. Hemodial Int 2007;11:86-95.
  2. Li PK, Kwan BC, Ko GT, Chow KM, Leung CB, Szeto CC: Treatment of metabolic syndrome in peritoneal dialysis patients. Perit Dial Int 2009;29(suppl 2):149–52. Rasić S, Hadzović-Dzuvo A, Rebić D, Uncanin S, Hadzić A, Mujaković A, Kulenović I: The metabolic syndrome in patients on peritoneal dialysis: prevalence and influence on cardiovascular morbidity. Bosn J Basic Med Sci 2010;10:3-7.
  3. Borazan A, Binici DN, Öztürk Y: Periton diyalizi hastalarında NCEP-ATP III ve IDF’ye göre metabolik sendrom sıklığı. Genel Tıp Dergisi 2011;21: 89- 94. Nath RK, Mridha MU, Sarker KR, Mollah FH, SFerdousi S, Rahman M: Metabolic Syndrome in Chronic Kidney Disease Patients. Dinajpur Medical College Journal 2012;5:34-8.
  4. Chen J, Muntner P, Hamm LL, Jones DW, Batuman V, Fonseca V, Whelton PK, He J: The metabolic syndrome and chronic kidney disease in US adults. Ann Intern Med 2004;140:167-74.
  5. Park SH, Lindholm B: Definition of metabolic syndrome in peritoneal dialysis. Perit Dial Int 2009;29:137-44.
  6. Kramer HJ, Saranathan A, Luke A, Durazo-Arvizu RA, Guichan C, Hou S, Cooper R: Increasing body mass index and obesity in the incident ESRD population. J Am Soc Nephrol. 2006;17:1453-9.
  7. Singh AK, Kari JA: Metabolic syndrome and chronic kidney disease. Curr Opin Nephrol Hypertens 2013;22:198-203.
  8. Gobal F, Deshmukh A, Shah S, Mehta JL: Triad of metabolic syndrome, chronic kidney disease, and coronary heart disease with a focus on microalbuminuria death by overeating. J Am Coll Cardiol 2011;57:2303- 8. Feldeisen SE, Tucker KL: Nutritional strategies in the prevention and treatment of metabolic syndrome. Appl Physiol Nutr Metab 2007;32:46-60. Lægreid IK, Aasarød K, Bye A, Leivestad T, Jordhøy M: The impact of nutritional status, physical function, comorbidity and early versus late start in dialysis on quality of life in older dialysis patients. Ren Fail 2014;36:9-16.
  9. Holmes, CJ: Reducing Cardiometabolic Risk in Peritoneal Dialysis Patients: Role of the Dialysis Solution Journal of Diabetes Science and Technology 2009;3:1472-80.
  10. Wiesen K, Mindel G: Dialysis, in nutrition and health. Nutr Kidney Dis 2008;3:231–62.
  11. Akbulut G, Sanlıer N, Inal S., Acar Tek N, Öneç K, Erten Y: Daily dietary energy and macronutrient intake and anthropometric measurements of the peritoneal dialysis patients. Renal Failure 2013; 35:56–61.
  12. Rakıcıoğlu N, Tek Acar N, Ayaz A, Pekcan G: Food and Nutrition Photo Catalog: dimensio